nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—CUBN—prostate gland—urinary bladder cancer	0.0102	0.0409	CbGeAlD
Hydroxocobalamin—Cyanocobalamin—MTHFR—urinary bladder cancer	0.0097	1	CrCbGaD
Hydroxocobalamin—MMAA—prostate gland—urinary bladder cancer	0.00969	0.0387	CbGeAlD
Hydroxocobalamin—TCN1—prostate gland—urinary bladder cancer	0.00922	0.0368	CbGeAlD
Hydroxocobalamin—MMAB—prostate gland—urinary bladder cancer	0.00908	0.0363	CbGeAlD
Hydroxocobalamin—CASP9—prostate gland—urinary bladder cancer	0.00849	0.0339	CbGeAlD
Hydroxocobalamin—AMN—renal system—urinary bladder cancer	0.00829	0.0331	CbGeAlD
Hydroxocobalamin—TCN2—prostate gland—urinary bladder cancer	0.00828	0.0331	CbGeAlD
Hydroxocobalamin—CUBN—epithelium—urinary bladder cancer	0.00753	0.03	CbGeAlD
Hydroxocobalamin—TCN2—seminal vesicle—urinary bladder cancer	0.00701	0.028	CbGeAlD
Hydroxocobalamin—CUBN—renal system—urinary bladder cancer	0.00698	0.0279	CbGeAlD
Hydroxocobalamin—CUBN—urethra—urinary bladder cancer	0.00686	0.0274	CbGeAlD
Hydroxocobalamin—MUT—prostate gland—urinary bladder cancer	0.00651	0.026	CbGeAlD
Hydroxocobalamin—TCN1—urethra—urinary bladder cancer	0.00617	0.0246	CbGeAlD
Hydroxocobalamin—MTRR—prostate gland—urinary bladder cancer	0.00585	0.0234	CbGeAlD
Hydroxocobalamin—CASP9—renal system—urinary bladder cancer	0.00578	0.0231	CbGeAlD
Hydroxocobalamin—TCN2—renal system—urinary bladder cancer	0.00565	0.0225	CbGeAlD
Hydroxocobalamin—CUBN—female reproductive system—urinary bladder cancer	0.00559	0.0223	CbGeAlD
Hydroxocobalamin—TCN2—urethra—urinary bladder cancer	0.00555	0.0221	CbGeAlD
Hydroxocobalamin—MUT—seminal vesicle—urinary bladder cancer	0.00551	0.022	CbGeAlD
Hydroxocobalamin—MTR—prostate gland—urinary bladder cancer	0.00511	0.0204	CbGeAlD
Hydroxocobalamin—MMAB—female reproductive system—urinary bladder cancer	0.00496	0.0198	CbGeAlD
Hydroxocobalamin—MTRR—seminal vesicle—urinary bladder cancer	0.00495	0.0198	CbGeAlD
Hydroxocobalamin—MMAA—vagina—urinary bladder cancer	0.00478	0.0191	CbGeAlD
Hydroxocobalamin—CASP9—female reproductive system—urinary bladder cancer	0.00463	0.0185	CbGeAlD
Hydroxocobalamin—TCN1—vagina—urinary bladder cancer	0.00455	0.0182	CbGeAlD
Hydroxocobalamin—TCN2—female reproductive system—urinary bladder cancer	0.00452	0.018	CbGeAlD
Hydroxocobalamin—MMAB—vagina—urinary bladder cancer	0.00448	0.0179	CbGeAlD
Hydroxocobalamin—MUT—renal system—urinary bladder cancer	0.00444	0.0177	CbGeAlD
Hydroxocobalamin—MUT—urethra—urinary bladder cancer	0.00436	0.0174	CbGeAlD
Hydroxocobalamin—MTR—seminal vesicle—urinary bladder cancer	0.00432	0.0172	CbGeAlD
Hydroxocobalamin—CASP9—vagina—urinary bladder cancer	0.00419	0.0167	CbGeAlD
Hydroxocobalamin—MTRR—renal system—urinary bladder cancer	0.00399	0.0159	CbGeAlD
Hydroxocobalamin—MTRR—urethra—urinary bladder cancer	0.00392	0.0156	CbGeAlD
Hydroxocobalamin—AMN—lymph node—urinary bladder cancer	0.00389	0.0155	CbGeAlD
Hydroxocobalamin—MUT—female reproductive system—urinary bladder cancer	0.00356	0.0142	CbGeAlD
Hydroxocobalamin—MTR—renal system—urinary bladder cancer	0.00348	0.0139	CbGeAlD
Hydroxocobalamin—MTR—urethra—urinary bladder cancer	0.00342	0.0136	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—urinary bladder cancer	0.00327	0.0131	CbGeAlD
Hydroxocobalamin—MUT—vagina—urinary bladder cancer	0.00322	0.0128	CbGeAlD
Hydroxocobalamin—MTRR—female reproductive system—urinary bladder cancer	0.0032	0.0128	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—urinary bladder cancer	0.00309	0.0123	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—urinary bladder cancer	0.0029	0.0116	CbGeAlD
Hydroxocobalamin—MTRR—vagina—urinary bladder cancer	0.00289	0.0115	CbGeAlD
Hydroxocobalamin—MTR—female reproductive system—urinary bladder cancer	0.00279	0.0111	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—urinary bladder cancer	0.00271	0.0108	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—urinary bladder cancer	0.00265	0.0106	CbGeAlD
Hydroxocobalamin—MTR—vagina—urinary bladder cancer	0.00252	0.0101	CbGeAlD
Hydroxocobalamin—MUT—lymph node—urinary bladder cancer	0.00208	0.0083	CbGeAlD
Hydroxocobalamin—MTRR—lymph node—urinary bladder cancer	0.00187	0.00746	CbGeAlD
Hydroxocobalamin—MTR—lymph node—urinary bladder cancer	0.00163	0.00651	CbGeAlD
Hydroxocobalamin—Urinary tract disorder—Etoposide—urinary bladder cancer	0.000644	0.00226	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Cisplatin—urinary bladder cancer	0.000643	0.00226	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.000642	0.00225	CcSEcCtD
Hydroxocobalamin—Infection—Thiotepa—urinary bladder cancer	0.000641	0.00225	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Etoposide—urinary bladder cancer	0.000639	0.00224	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Cisplatin—urinary bladder cancer	0.000636	0.00223	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000633	0.00222	CcSEcCtD
Hydroxocobalamin—Tachycardia—Thiotepa—urinary bladder cancer	0.00063	0.00221	CcSEcCtD
Hydroxocobalamin—Skin disorder—Thiotepa—urinary bladder cancer	0.000627	0.0022	CcSEcCtD
Hydroxocobalamin—Erythema—Cisplatin—urinary bladder cancer	0.00062	0.00218	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000617	0.00217	CcSEcCtD
Hydroxocobalamin—Phlebitis—Epirubicin—urinary bladder cancer	0.000613	0.00215	CcSEcCtD
Hydroxocobalamin—Eye disorder—Etoposide—urinary bladder cancer	0.00061	0.00214	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Etoposide—urinary bladder cancer	0.000605	0.00213	CcSEcCtD
Hydroxocobalamin—Malaise—Gemcitabine—urinary bladder cancer	0.0006	0.00211	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—urinary bladder cancer	0.0006	0.00211	CcSEcCtD
Hydroxocobalamin—Angiopathy—Etoposide—urinary bladder cancer	0.000592	0.00208	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Etoposide—urinary bladder cancer	0.000589	0.00207	CcSEcCtD
Hydroxocobalamin—Eczema—Epirubicin—urinary bladder cancer	0.000588	0.00206	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Etoposide—urinary bladder cancer	0.000588	0.00206	CcSEcCtD
Hydroxocobalamin—Chills—Etoposide—urinary bladder cancer	0.000585	0.00205	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.000583	0.00205	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000575	0.00202	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Thiotepa—urinary bladder cancer	0.000568	0.00199	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—urinary bladder cancer	0.000568	0.00199	CcSEcCtD
Hydroxocobalamin—Chest pain—Gemcitabine—urinary bladder cancer	0.000566	0.00199	CcSEcCtD
Hydroxocobalamin—Hot flush—Epirubicin—urinary bladder cancer	0.000565	0.00198	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000562	0.00197	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Epirubicin—urinary bladder cancer	0.00056	0.00197	CcSEcCtD
Hydroxocobalamin—Discomfort—Gemcitabine—urinary bladder cancer	0.000559	0.00196	CcSEcCtD
Hydroxocobalamin—Malaise—Cisplatin—urinary bladder cancer	0.000559	0.00196	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000557	0.00196	CcSEcCtD
Hydroxocobalamin—Chest pain—Fluorouracil—urinary bladder cancer	0.000557	0.00195	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.000553	0.00194	CcSEcCtD
Hydroxocobalamin—Pain—Thiotepa—urinary bladder cancer	0.000552	0.00194	CcSEcCtD
Hydroxocobalamin—Discomfort—Fluorouracil—urinary bladder cancer	0.00055	0.00193	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—urinary bladder cancer	0.000544	0.00191	CcSEcCtD
Hydroxocobalamin—Oedema—Gemcitabine—urinary bladder cancer	0.000543	0.00191	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000543	0.00191	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.000539	0.00189	CcSEcCtD
Hydroxocobalamin—Infection—Gemcitabine—urinary bladder cancer	0.000539	0.00189	CcSEcCtD
Hydroxocobalamin—Oedema—Fluorouracil—urinary bladder cancer	0.000534	0.00187	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000534	0.00187	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000532	0.00187	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000532	0.00187	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Epirubicin—urinary bladder cancer	0.000531	0.00186	CcSEcCtD
Hydroxocobalamin—Infection—Fluorouracil—urinary bladder cancer	0.00053	0.00186	CcSEcCtD
Hydroxocobalamin—Skin disorder—Gemcitabine—urinary bladder cancer	0.000527	0.00185	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000527	0.00185	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000524	0.00184	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000523	0.00184	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—urinary bladder cancer	0.000523	0.00184	CcSEcCtD
Hydroxocobalamin—Discomfort—Cisplatin—urinary bladder cancer	0.000521	0.00183	CcSEcCtD
Hydroxocobalamin—Tachycardia—Fluorouracil—urinary bladder cancer	0.000521	0.00183	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—urinary bladder cancer	0.000518	0.00182	CcSEcCtD
Hydroxocobalamin—Urticaria—Thiotepa—urinary bladder cancer	0.000512	0.0018	CcSEcCtD
Hydroxocobalamin—Malaise—Etoposide—urinary bladder cancer	0.000512	0.0018	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.000512	0.0018	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Thiotepa—urinary bladder cancer	0.00051	0.00179	CcSEcCtD
Hydroxocobalamin—Oedema—Cisplatin—urinary bladder cancer	0.000506	0.00178	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000506	0.00178	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000503	0.00176	CcSEcCtD
Hydroxocobalamin—Infection—Cisplatin—urinary bladder cancer	0.000502	0.00176	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000496	0.00174	CcSEcCtD
Hydroxocobalamin—Tachycardia—Cisplatin—urinary bladder cancer	0.000494	0.00173	CcSEcCtD
Hydroxocobalamin—Skin disorder—Cisplatin—urinary bladder cancer	0.000491	0.00172	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.000491	0.00172	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000484	0.0017	CcSEcCtD
Hydroxocobalamin—Chest pain—Etoposide—urinary bladder cancer	0.000483	0.0017	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000481	0.00169	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00048	0.00169	CcSEcCtD
Hydroxocobalamin—Discomfort—Etoposide—urinary bladder cancer	0.000478	0.00168	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000476	0.00167	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000475	0.00167	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00047	0.00165	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000468	0.00164	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000468	0.00164	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000465	0.00163	CcSEcCtD
Hydroxocobalamin—Pain—Gemcitabine—urinary bladder cancer	0.000464	0.00163	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000463	0.00163	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000461	0.00162	CcSEcCtD
Hydroxocobalamin—Infection—Etoposide—urinary bladder cancer	0.00046	0.00162	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—urinary bladder cancer	0.000457	0.0016	CcSEcCtD
Hydroxocobalamin—Pruritus—Thiotepa—urinary bladder cancer	0.000456	0.0016	CcSEcCtD
Hydroxocobalamin—Pain—Fluorouracil—urinary bladder cancer	0.000456	0.0016	CcSEcCtD
Hydroxocobalamin—Tachycardia—Etoposide—urinary bladder cancer	0.000452	0.00159	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Cisplatin—urinary bladder cancer	0.000451	0.00158	CcSEcCtD
Hydroxocobalamin—Skin disorder—Etoposide—urinary bladder cancer	0.00045	0.00158	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000447	0.00157	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000445	0.00156	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000441	0.00155	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00044	0.00154	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000437	0.00153	CcSEcCtD
Hydroxocobalamin—Pain—Cisplatin—urinary bladder cancer	0.000433	0.00152	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000429	0.00151	CcSEcCtD
Hydroxocobalamin—Dizziness—Thiotepa—urinary bladder cancer	0.000427	0.0015	CcSEcCtD
Hydroxocobalamin—Urticaria—Fluorouracil—urinary bladder cancer	0.000424	0.00149	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—urinary bladder cancer	0.000423	0.00148	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000422	0.00148	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000417	0.00146	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Etoposide—urinary bladder cancer	0.000413	0.00145	CcSEcCtD
Hydroxocobalamin—Rash—Thiotepa—urinary bladder cancer	0.000407	0.00143	CcSEcCtD
Hydroxocobalamin—Dermatitis—Thiotepa—urinary bladder cancer	0.000406	0.00143	CcSEcCtD
Hydroxocobalamin—Headache—Thiotepa—urinary bladder cancer	0.000404	0.00142	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.0004	0.0014	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Cisplatin—urinary bladder cancer	0.0004	0.0014	CcSEcCtD
Hydroxocobalamin—Pain—Etoposide—urinary bladder cancer	0.000396	0.00139	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000393	0.00138	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000386	0.00135	CcSEcCtD
Hydroxocobalamin—Pruritus—Gemcitabine—urinary bladder cancer	0.000384	0.00135	CcSEcCtD
Hydroxocobalamin—Nausea—Thiotepa—urinary bladder cancer	0.000383	0.00135	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Methotrexate—urinary bladder cancer	0.000383	0.00134	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000382	0.00134	CcSEcCtD
Hydroxocobalamin—Pruritus—Fluorouracil—urinary bladder cancer	0.000377	0.00133	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000373	0.00131	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000371	0.0013	CcSEcCtD
Hydroxocobalamin—Urticaria—Etoposide—urinary bladder cancer	0.000368	0.00129	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Etoposide—urinary bladder cancer	0.000366	0.00129	CcSEcCtD
Hydroxocobalamin—Eye disorder—Methotrexate—urinary bladder cancer	0.000365	0.00128	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000365	0.00128	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000363	0.00127	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000361	0.00127	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00036	0.00126	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—urinary bladder cancer	0.000358	0.00126	CcSEcCtD
Hydroxocobalamin—Angiopathy—Methotrexate—urinary bladder cancer	0.000354	0.00124	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000353	0.00124	CcSEcCtD
Hydroxocobalamin—Dizziness—Fluorouracil—urinary bladder cancer	0.000353	0.00124	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000352	0.00124	CcSEcCtD
Hydroxocobalamin—Chills—Methotrexate—urinary bladder cancer	0.000351	0.00123	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000346	0.00122	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methotrexate—urinary bladder cancer	0.000342	0.0012	CcSEcCtD
Hydroxocobalamin—Rash—Gemcitabine—urinary bladder cancer	0.000342	0.0012	CcSEcCtD
Hydroxocobalamin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000342	0.0012	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—urinary bladder cancer	0.000342	0.0012	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000341	0.0012	CcSEcCtD
Hydroxocobalamin—Erythema—Methotrexate—urinary bladder cancer	0.00034	0.00119	CcSEcCtD
Hydroxocobalamin—Headache—Gemcitabine—urinary bladder cancer	0.00034	0.00119	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000339	0.00119	CcSEcCtD
Hydroxocobalamin—Rash—Fluorouracil—urinary bladder cancer	0.000336	0.00118	CcSEcCtD
Hydroxocobalamin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000336	0.00118	CcSEcCtD
Hydroxocobalamin—Headache—Fluorouracil—urinary bladder cancer	0.000334	0.00117	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000334	0.00117	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000333	0.00117	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—urinary bladder cancer	0.000332	0.00116	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000332	0.00116	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—urinary bladder cancer	0.00033	0.00116	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000329	0.00116	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—urinary bladder cancer	0.000328	0.00115	CcSEcCtD
Hydroxocobalamin—Pruritus—Etoposide—urinary bladder cancer	0.000328	0.00115	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000327	0.00115	CcSEcCtD
Hydroxocobalamin—Nausea—Gemcitabine—urinary bladder cancer	0.000322	0.00113	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—urinary bladder cancer	0.00032	0.00112	CcSEcCtD
Hydroxocobalamin—Rash—Cisplatin—urinary bladder cancer	0.000319	0.00112	CcSEcCtD
Hydroxocobalamin—Dermatitis—Cisplatin—urinary bladder cancer	0.000319	0.00112	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—urinary bladder cancer	0.000318	0.00112	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Etoposide—urinary bladder cancer	0.000317	0.00111	CcSEcCtD
Hydroxocobalamin—Nausea—Fluorouracil—urinary bladder cancer	0.000317	0.00111	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000316	0.00111	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000316	0.00111	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000314	0.0011	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000307	0.00108	CcSEcCtD
Hydroxocobalamin—Malaise—Methotrexate—urinary bladder cancer	0.000307	0.00108	CcSEcCtD
Hydroxocobalamin—Dizziness—Etoposide—urinary bladder cancer	0.000306	0.00108	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000306	0.00107	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000305	0.00107	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—urinary bladder cancer	0.000304	0.00107	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000302	0.00106	CcSEcCtD
Hydroxocobalamin—Nausea—Cisplatin—urinary bladder cancer	0.0003	0.00105	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000296	0.00104	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000295	0.00104	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—urinary bladder cancer	0.000294	0.00103	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—urinary bladder cancer	0.000292	0.00103	CcSEcCtD
Hydroxocobalamin—Rash—Etoposide—urinary bladder cancer	0.000292	0.00103	CcSEcCtD
Hydroxocobalamin—Dermatitis—Etoposide—urinary bladder cancer	0.000292	0.00102	CcSEcCtD
Hydroxocobalamin—Headache—Etoposide—urinary bladder cancer	0.00029	0.00102	CcSEcCtD
Hydroxocobalamin—Chest pain—Methotrexate—urinary bladder cancer	0.00029	0.00102	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000288	0.00101	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—urinary bladder cancer	0.000287	0.00101	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—urinary bladder cancer	0.000286	0.001	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000278	0.000974	CcSEcCtD
Hydroxocobalamin—Infection—Methotrexate—urinary bladder cancer	0.000276	0.000968	CcSEcCtD
Hydroxocobalamin—Nausea—Etoposide—urinary bladder cancer	0.000275	0.000966	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000273	0.000959	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000272	0.000956	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—urinary bladder cancer	0.000271	0.000951	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—urinary bladder cancer	0.000271	0.00095	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—urinary bladder cancer	0.00027	0.000947	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000269	0.000945	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—urinary bladder cancer	0.000268	0.00094	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—urinary bladder cancer	0.000266	0.000932	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00026	0.000912	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—urinary bladder cancer	0.00026	0.000912	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—urinary bladder cancer	0.000258	0.000906	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000255	0.000894	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—urinary bladder cancer	0.000254	0.00089	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—urinary bladder cancer	0.000252	0.000886	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—urinary bladder cancer	0.000251	0.00088	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000249	0.000874	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—urinary bladder cancer	0.000248	0.00087	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000247	0.000869	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000244	0.000858	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00024	0.000844	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—urinary bladder cancer	0.00024	0.000844	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00024	0.000841	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—urinary bladder cancer	0.000239	0.000838	CcSEcCtD
Hydroxocobalamin—Pain—Methotrexate—urinary bladder cancer	0.000237	0.000833	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000236	0.000827	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000235	0.000824	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000233	0.00082	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000232	0.000813	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000229	0.000803	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000229	0.000803	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000224	0.000787	CcSEcCtD
Hydroxocobalamin—Pain—Epirubicin—urinary bladder cancer	0.000222	0.00078	CcSEcCtD
Hydroxocobalamin—Urticaria—Methotrexate—urinary bladder cancer	0.00022	0.000774	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000219	0.00077	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000214	0.000752	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000214	0.000751	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000212	0.000743	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000207	0.000728	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—urinary bladder cancer	0.000206	0.000724	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—urinary bladder cancer	0.000206	0.000722	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000205	0.000721	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000204	0.000718	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000198	0.000695	CcSEcCtD
Hydroxocobalamin—Pruritus—Methotrexate—urinary bladder cancer	0.000196	0.000689	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000191	0.000672	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—urinary bladder cancer	0.000191	0.00067	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00019	0.000667	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Methotrexate—urinary bladder cancer	0.00019	0.000667	CcSEcCtD
Hydroxocobalamin—Pruritus—Epirubicin—urinary bladder cancer	0.000184	0.000645	CcSEcCtD
Hydroxocobalamin—Dizziness—Methotrexate—urinary bladder cancer	0.000184	0.000644	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000178	0.000624	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000177	0.000622	CcSEcCtD
Hydroxocobalamin—Rash—Methotrexate—urinary bladder cancer	0.000175	0.000614	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—urinary bladder cancer	0.000175	0.000614	CcSEcCtD
Hydroxocobalamin—Headache—Methotrexate—urinary bladder cancer	0.000174	0.00061	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—urinary bladder cancer	0.000172	0.000603	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—urinary bladder cancer	0.00017	0.000597	CcSEcCtD
Hydroxocobalamin—Nausea—Methotrexate—urinary bladder cancer	0.000165	0.000579	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000164	0.000577	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—urinary bladder cancer	0.000164	0.000575	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—urinary bladder cancer	0.000164	0.000574	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—urinary bladder cancer	0.000163	0.000571	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—urinary bladder cancer	0.000159	0.000558	CcSEcCtD
Hydroxocobalamin—Nausea—Epirubicin—urinary bladder cancer	0.000154	0.000542	CcSEcCtD
Hydroxocobalamin—Rash—Doxorubicin—urinary bladder cancer	0.000152	0.000532	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000151	0.000532	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—urinary bladder cancer	0.000151	0.000529	CcSEcCtD
Hydroxocobalamin—Nausea—Doxorubicin—urinary bladder cancer	0.000143	0.000501	CcSEcCtD
Hydroxocobalamin—MUT—Disease—CREBBP—urinary bladder cancer	7.21e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—MTHFR—urinary bladder cancer	7.16e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CDKN1A—urinary bladder cancer	7.14e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PTEN—urinary bladder cancer	7.13e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—CREBBP—urinary bladder cancer	7.11e-05	0.000156	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—ERBB2—urinary bladder cancer	7.11e-05	0.000156	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—NQO1—urinary bladder cancer	7.07e-05	0.000156	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—FGFR3—urinary bladder cancer	7.04e-05	0.000155	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MTHFR—urinary bladder cancer	7.02e-05	0.000154	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TERT—urinary bladder cancer	7e-05	0.000154	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTGS2—urinary bladder cancer	6.95e-05	0.000153	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—HRAS—urinary bladder cancer	6.93e-05	0.000152	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTGS2—urinary bladder cancer	6.84e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—RHOA—urinary bladder cancer	6.84e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—RHOA—urinary bladder cancer	6.84e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EP300—urinary bladder cancer	6.8e-05	0.000149	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—TYMS—urinary bladder cancer	6.73e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—JAG1—urinary bladder cancer	6.69e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CREBBP—urinary bladder cancer	6.66e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GSTM1—urinary bladder cancer	6.65e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—NCOR1—urinary bladder cancer	6.65e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—HRAS—urinary bladder cancer	6.63e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—SRC—urinary bladder cancer	6.61e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PPARG—urinary bladder cancer	6.59e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PPARG—urinary bladder cancer	6.59e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CDKN1A—urinary bladder cancer	6.53e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CDKN1A—urinary bladder cancer	6.53e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—RHOA—urinary bladder cancer	6.53e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTEN—urinary bladder cancer	6.52e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PTEN—urinary bladder cancer	6.52e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NCOR1—urinary bladder cancer	6.47e-05	0.000142	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—FGFR3—urinary bladder cancer	6.42e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GPX1—urinary bladder cancer	6.37e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—EGFR—urinary bladder cancer	6.35e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—CREBBP—urinary bladder cancer	6.33e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—CREBBP—urinary bladder cancer	6.33e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—ERBB2—urinary bladder cancer	6.33e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—ERBB2—urinary bladder cancer	6.33e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PPARG—urinary bladder cancer	6.29e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—urinary bladder cancer	6.26e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—urinary bladder cancer	6.26e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ERCC2—urinary bladder cancer	6.25e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CREBBP—urinary bladder cancer	6.24e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EP300—urinary bladder cancer	6.22e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EP300—urinary bladder cancer	6.22e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNA2—urinary bladder cancer	6.21e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTGS2—urinary bladder cancer	6.19e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—urinary bladder cancer	6.19e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERCC2—urinary bladder cancer	6.09e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CDKN1A—urinary bladder cancer	6.07e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTEN—urinary bladder cancer	6.06e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—SRC—urinary bladder cancer	6.04e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—SRC—urinary bladder cancer	6.04e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—CREBBP—urinary bladder cancer	6.04e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—ERBB2—urinary bladder cancer	6.04e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—RHOA—urinary bladder cancer	6.02e-05	0.000132	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KRAS—urinary bladder cancer	6e-05	0.000132	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTEN—urinary bladder cancer	5.97e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDH1—urinary bladder cancer	5.95e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MYC—urinary bladder cancer	5.92e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—urinary bladder cancer	5.91e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GSTP1—urinary bladder cancer	5.9e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—MTHFR—urinary bladder cancer	5.88e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—S100B—urinary bladder cancer	5.87e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—urinary bladder cancer	5.82e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PPARG—urinary bladder cancer	5.8e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EGFR—urinary bladder cancer	5.79e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EP300—urinary bladder cancer	5.78e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTHFR—urinary bladder cancer	5.72e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TERT—urinary bladder cancer	5.71e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—EP300—urinary bladder cancer	5.69e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—SRC—urinary bladder cancer	5.62e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—CREBBP—urinary bladder cancer	5.58e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—ERBB2—urinary bladder cancer	5.58e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—TYMS—urinary bladder cancer	5.49e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KRAS—urinary bladder cancer	5.47e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CREBBP—urinary bladder cancer	5.47e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTEN—urinary bladder cancer	5.46e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTEN—urinary bladder cancer	5.46e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—urinary bladder cancer	5.45e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GSTM1—urinary bladder cancer	5.42e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—NCOR1—urinary bladder cancer	5.42e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MYC—urinary bladder cancer	5.42e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MYC—urinary bladder cancer	5.42e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CDKN1A—urinary bladder cancer	5.41e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CDKN1A—urinary bladder cancer	5.41e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTEN—urinary bladder cancer	5.4e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTEN—urinary bladder cancer	5.4e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EGFR—urinary bladder cancer	5.3e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EGFR—urinary bladder cancer	5.3e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RBX1—urinary bladder cancer	5.24e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FGFR3—urinary bladder cancer	5.24e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—ERBB2—urinary bladder cancer	5.23e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—EP300—urinary bladder cancer	5.21e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—EP300—urinary bladder cancer	5.21e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GPX1—urinary bladder cancer	5.19e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—urinary bladder cancer	5.19e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—urinary bladder cancer	5.19e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CDKN1A—urinary bladder cancer	5.16e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTEN—urinary bladder cancer	5.15e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EP300—urinary bladder cancer	5.15e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EP300—urinary bladder cancer	5.15e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—HRAS—urinary bladder cancer	5.1e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ERCC2—urinary bladder cancer	5.1e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTEN—urinary bladder cancer	5.07e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MYC—urinary bladder cancer	5.04e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ERBB2—urinary bladder cancer	5.02e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—SRC—urinary bladder cancer	5.01e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—SRC—urinary bladder cancer	5.01e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—urinary bladder cancer	5.01e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—urinary bladder cancer	5.01e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—urinary bladder cancer	4.95e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—RHOA—urinary bladder cancer	4.95e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—urinary bladder cancer	4.93e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TSC1—urinary bladder cancer	4.92e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EP300—urinary bladder cancer	4.91e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NCOR1—urinary bladder cancer	4.87e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—EP300—urinary bladder cancer	4.84e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—MTHFR—urinary bladder cancer	4.79e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—SRC—urinary bladder cancer	4.78e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARG—urinary bladder cancer	4.77e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CDKN1A—urinary bladder cancer	4.77e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTEN—urinary bladder cancer	4.76e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JAG1—urinary bladder cancer	4.69e-05	0.000103	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—urinary bladder cancer	4.65e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HRAS—urinary bladder cancer	4.65e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERCC2—urinary bladder cancer	4.58e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CREBBP—urinary bladder cancer	4.58e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ERBB2—urinary bladder cancer	4.58e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—urinary bladder cancer	4.57e-05	0.0001	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EP300—urinary bladder cancer	4.53e-05	9.97e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTEN—urinary bladder cancer	4.52e-05	9.94e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTEN—urinary bladder cancer	4.52e-05	9.94e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MYC—urinary bladder cancer	4.49e-05	9.87e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MYC—urinary bladder cancer	4.49e-05	9.87e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—urinary bladder cancer	4.48e-05	9.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CDKN1A—urinary bladder cancer	4.47e-05	9.82e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CREBBP—urinary bladder cancer	4.46e-05	9.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PTEN—urinary bladder cancer	4.46e-05	9.8e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—SRC—urinary bladder cancer	4.41e-05	9.69e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—urinary bladder cancer	4.39e-05	9.65e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—urinary bladder cancer	4.39e-05	9.65e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTEN—urinary bladder cancer	4.32e-05	9.48e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—EP300—urinary bladder cancer	4.31e-05	9.48e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—EP300—urinary bladder cancer	4.31e-05	9.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTHFR—urinary bladder cancer	4.31e-05	9.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TERT—urinary bladder cancer	4.3e-05	9.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDKN1A—urinary bladder cancer	4.29e-05	9.43e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MYC—urinary bladder cancer	4.28e-05	9.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PTEN—urinary bladder cancer	4.28e-05	9.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGFR3—urinary bladder cancer	4.27e-05	9.39e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—urinary bladder cancer	4.25e-05	9.35e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—urinary bladder cancer	4.25e-05	9.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EP300—urinary bladder cancer	4.25e-05	9.34e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—urinary bladder cancer	4.19e-05	9.21e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—urinary bladder cancer	4.15e-05	9.12e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—urinary bladder cancer	4.15e-05	9.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—SRC—urinary bladder cancer	4.13e-05	9.08e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—EP300—urinary bladder cancer	4.12e-05	9.05e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—RHOA—urinary bladder cancer	4.03e-05	8.86e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—urinary bladder cancer	3.98e-05	8.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—SRC—urinary bladder cancer	3.97e-05	8.72e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—urinary bladder cancer	3.96e-05	8.7e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—urinary bladder cancer	3.96e-05	8.69e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—urinary bladder cancer	3.95e-05	8.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGFR3—urinary bladder cancer	3.94e-05	8.67e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1A—urinary bladder cancer	3.91e-05	8.6e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—urinary bladder cancer	3.9e-05	8.58e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARG—urinary bladder cancer	3.89e-05	8.54e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—urinary bladder cancer	3.87e-05	8.5e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—EP300—urinary bladder cancer	3.8e-05	8.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—S100B—urinary bladder cancer	3.8e-05	8.34e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—urinary bladder cancer	3.75e-05	8.24e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CREBBP—urinary bladder cancer	3.73e-05	8.21e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—urinary bladder cancer	3.73e-05	8.21e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EP300—urinary bladder cancer	3.72e-05	8.19e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—urinary bladder cancer	3.65e-05	8.03e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—urinary bladder cancer	3.65e-05	8.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CREBBP—urinary bladder cancer	3.63e-05	7.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—urinary bladder cancer	3.62e-05	7.96e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SRC—urinary bladder cancer	3.62e-05	7.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDH1—urinary bladder cancer	3.61e-05	7.93e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—urinary bladder cancer	3.53e-05	7.75e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—urinary bladder cancer	3.53e-05	7.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—urinary bladder cancer	3.48e-05	7.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—urinary bladder cancer	3.42e-05	7.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NCOR1—urinary bladder cancer	3.41e-05	7.5e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—urinary bladder cancer	3.36e-05	7.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CREBBP—urinary bladder cancer	3.36e-05	7.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—urinary bladder cancer	3.29e-05	7.22e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—urinary bladder cancer	3.27e-05	7.19e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—urinary bladder cancer	3.25e-05	7.13e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1A—urinary bladder cancer	3.19e-05	7.01e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—urinary bladder cancer	3.18e-05	7e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—urinary bladder cancer	3.17e-05	6.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—EP300—urinary bladder cancer	3.12e-05	6.86e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—urinary bladder cancer	3.1e-05	6.82e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—urinary bladder cancer	3.06e-05	6.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—urinary bladder cancer	3.04e-05	6.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—RHOA—urinary bladder cancer	3.04e-05	6.67e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EP300—urinary bladder cancer	3.04e-05	6.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—urinary bladder cancer	3.01e-05	6.61e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—urinary bladder cancer	3e-05	6.59e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SRC—urinary bladder cancer	2.95e-05	6.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—urinary bladder cancer	2.91e-05	6.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—urinary bladder cancer	2.81e-05	6.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—urinary bladder cancer	2.79e-05	6.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGFR3—urinary bladder cancer	2.76e-05	6.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—urinary bladder cancer	2.76e-05	6.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—urinary bladder cancer	2.75e-05	6.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ESR1—urinary bladder cancer	2.68e-05	5.89e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—urinary bladder cancer	2.67e-05	5.86e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—urinary bladder cancer	2.65e-05	5.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1A—urinary bladder cancer	2.6e-05	5.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—urinary bladder cancer	2.6e-05	5.71e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—urinary bladder cancer	2.59e-05	5.69e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—urinary bladder cancer	2.55e-05	5.6e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—EP300—urinary bladder cancer	2.54e-05	5.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EP300—urinary bladder cancer	2.48e-05	5.44e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—urinary bladder cancer	2.44e-05	5.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SRC—urinary bladder cancer	2.41e-05	5.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1A—urinary bladder cancer	2.4e-05	5.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—urinary bladder cancer	2.4e-05	5.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CREBBP—urinary bladder cancer	2.35e-05	5.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1—urinary bladder cancer	2.32e-05	5.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EP300—urinary bladder cancer	2.29e-05	5.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SRC—urinary bladder cancer	2.22e-05	4.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RHOA—urinary bladder cancer	2.13e-05	4.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—urinary bladder cancer	2.11e-05	4.64e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—urinary bladder cancer	2.08e-05	4.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—urinary bladder cancer	1.99e-05	4.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—urinary bladder cancer	1.99e-05	4.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—urinary bladder cancer	1.97e-05	4.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—urinary bladder cancer	1.95e-05	4.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL8—urinary bladder cancer	1.87e-05	4.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—urinary bladder cancer	1.84e-05	4.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—urinary bladder cancer	1.78e-05	3.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—urinary bladder cancer	1.74e-05	3.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—urinary bladder cancer	1.69e-05	3.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—urinary bladder cancer	1.69e-05	3.71e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1A—urinary bladder cancer	1.68e-05	3.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—urinary bladder cancer	1.68e-05	3.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EP300—urinary bladder cancer	1.6e-05	3.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—urinary bladder cancer	1.56e-05	3.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SRC—urinary bladder cancer	1.56e-05	3.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—urinary bladder cancer	1.39e-05	3.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—urinary bladder cancer	1.36e-05	3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—urinary bladder cancer	1.29e-05	2.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—urinary bladder cancer	1.15e-05	2.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—urinary bladder cancer	1.1e-05	2.41e-05	CbGpPWpGaD
